Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Davis

Showing results (51-60 of 164) with videos related to

Pageof 17
Sort By:
The Annals of Thoracic Surgery|March 1, 1997
Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertensionE P Chen, H B Bittner, R D Davis, et al.
Environmental Pollution (Barking, Essex : 1987)|January 1, 1988
Distribution of metals in grassland soils following surface applications of sewage sludgeR D Davis, C H Carlton-Smith, J H Stark, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 29, 2005
A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beingsS Keshavjee, R D Davis, M R Zamora, et al.
Phytopathology|October 24, 2008
Genetic Variation Among Vegetative Compatibility Groups of Fusarium oxysporum f. sp. cubense Analyzed by DNA FingerprintingS Bentley, K G Pegg, N Y Moore, et al.
Circulation|May 21, 1998
Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertensionE P Chen, D M Craig, H B Bittner, et al.
Cancer Treatment Reports|October 1, 1976
Inhibitors of L-asparagine synthetase, in vitroD A Cooney, J S Driscoll, H A Milman, et al.
Clinical Immunology (Orlando, Fla.)|February 13, 2001
Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab)G V Gonzalez-Stawinski, P B Yu, S D Love, et al.
General Dentistry|February 24, 2001
Systemic effects of an intraosseous injection of 2% lidocaine with 1:100,000 epinephrineT M Chamberlain, R D Davis, D F Murchison, et al.
Toxicology and Applied Pharmacology|August 1, 1972
The stoichiometric fate of azaserine metabolized in vitro by tissues from azaserine-treated dogs and miceH Rosenkrantz, R Sprague, U Schaeppi, et al.
British Journal of Pharmacology|January 1, 1971
Studies on the inhibition of clearance of organic dyes by SaramycetinD A Cooney, R D Davis, E R Homan, et al.
Pageof 17

Showing results (51-60 of 164) with videos related to

Sort By:
Pageof 17
The Annals of Thoracic Surgery|March 1, 1997
Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertensionE P Chen, H B Bittner, R D Davis, et al.
Environmental Pollution (Barking, Essex : 1987)|January 1, 1988
Distribution of metals in grassland soils following surface applications of sewage sludgeR D Davis, C H Carlton-Smith, J H Stark, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 29, 2005
A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beingsS Keshavjee, R D Davis, M R Zamora, et al.
Phytopathology|October 24, 2008
Genetic Variation Among Vegetative Compatibility Groups of Fusarium oxysporum f. sp. cubense Analyzed by DNA FingerprintingS Bentley, K G Pegg, N Y Moore, et al.
Circulation|May 21, 1998
Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertensionE P Chen, D M Craig, H B Bittner, et al.
Cancer Treatment Reports|October 1, 1976
Inhibitors of L-asparagine synthetase, in vitroD A Cooney, J S Driscoll, H A Milman, et al.
Clinical Immunology (Orlando, Fla.)|February 13, 2001
Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab)G V Gonzalez-Stawinski, P B Yu, S D Love, et al.
General Dentistry|February 24, 2001
Systemic effects of an intraosseous injection of 2% lidocaine with 1:100,000 epinephrineT M Chamberlain, R D Davis, D F Murchison, et al.
Toxicology and Applied Pharmacology|August 1, 1972
The stoichiometric fate of azaserine metabolized in vitro by tissues from azaserine-treated dogs and miceH Rosenkrantz, R Sprague, U Schaeppi, et al.
British Journal of Pharmacology|January 1, 1971
Studies on the inhibition of clearance of organic dyes by SaramycetinD A Cooney, R D Davis, E R Homan, et al.
Pageof 17